RxDoctor Payments Data

Lisa Peterson, MD

Family Medicine · Lincoln, NENPI 1073682993

Payments from drug & device makers

$6,927in general payments, 2019–2025

Across 453 payments — averaging $15.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • AbbVie$1K
  • Novo Nordisk$781
  • Lilly USA, LLC$400
  • Astellas Pharma US Inc$374
  • Pfizer$336
  • plus $3K from 42 others

What the payments were for

  • Food & beverage$6,82599%
  • Education$1021%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,927 in reported general payments places this provider in the 90th percentile of 981 family medicine providers in Nebraska.

See all family medicine providers in Nebraska

Medicare billing

Part B allowed, 2024
$243,597
Medicare patients
401
Services billed
2,945

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide149$162,354
JardianceEmpagliflozin120$102,268
EliquisApixaban153$96,179
RybelsusSemaglutide78$79,158
MounjaroTirzepatide64$73,200
FarxigaDapagliflozin Propanediol54$55,987
XareltoRivaroxaban49$39,286
Repatha SureclickEvolocumab29$27,762
TrulicityDulaglutide28$26,638
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$26,079
JanuviaSitagliptin Phosphate40$23,516
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr26$12,144
LinzessLinaclotide18$12,136
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog25$10,655
NeuproRotigotine12$9,688

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$781$241,511227 claims
Boehringer IngelheimJardiance$174$102,268120 claims
Lilly USA, LLCMounjaro, Trulicity$400$99,83892 claims
PfizerEliquis$336$96,179153 claims
AstraZenecaFarxiga$241$55,98754 claims
Johnson & JohnsonXarelto$115$39,28649 claims
GSKTrelegy Ellipta, Anoro Ellipta$179$38,22356 claims
MerckJanuvia$69$23,51640 claims
AbbVieLinzess, Synthroid$1,029$16,27373 claims
Kowa Pharmaceuticals America, Inc.Livalo$166$6,12413 claims
Collegium Pharmaceutical, Inc.Belbuca$22$5,92017 claims
Astellas Pharma US IncMyrbetriq$374$5,48313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 981 family medicine providers in Nebraska.

Other family medicine in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →